{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:52:06Z","timestamp":1791175926574,"version":"4.1.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-026-10432-y","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:17:44Z","timestamp":1791173864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosome-mediated organotropism in breast cancer metastasis: bridging the gap between molecular mechanisms and clinical application"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0106-9894","authenticated-orcid":false,"given":"Danil A.","family":"Pegushin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-5179","authenticated-orcid":false,"given":"Marine V.","family":"Oganesyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9532-9957","authenticated-orcid":false,"given":"Vladimir N.","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"10432_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12935-024-03464-5","volume":"24","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Rajendran RL, Mahajan AA et al (2024) Harnessing exosomes as cancer biomarkers in clinical oncology. Cancer Cell Int 24:278. https:\/\/doi.org\/10.1186\/s12935-024-03464-5","journal-title":"Cancer Cell Int"},{"key":"10432_CR2","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-024-12329-w","volume":"271","author":"H Tao","year":"2024","unstructured":"Tao H, Gao B (2024) Exosomes for neurodegenerative diseases: diagnosis and targeted therapy. J Neurol 271:3050\u20133062. https:\/\/doi.org\/10.1007\/s00415-024-12329-w","journal-title":"J Neurol"},{"issue":"9","key":"10432_CR3","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1021\/acs.molpharmaceut.3c00268","volume":"20","author":"N Li","year":"2023","unstructured":"Li N, Zhang T, Zhu L, Sun L, Shao G, Gao J (2023) Recent advances of using exosomes as diagnostic markers and targeting carriers for cardiovascular disease. Mol Pharm 20(9):4354\u20134372. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00268","journal-title":"Mol Pharm"},{"key":"10432_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10585-025-10377-8","volume":"42","author":"CD Coronado-Alvarado","year":"2025","unstructured":"Coronado-Alvarado CD, Astiazaran-Garcia H (2025) Defining the Tumor-Bone axis: the role of extracellular vesicles in a crucial exchange route for breast cancer development and progression. Clin Exp Metastasis 42:59. https:\/\/doi.org\/10.1007\/s10585-025-10377-8","journal-title":"Clin Exp Metastasis"},{"key":"10432_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12943-025-02358-y","volume":"24","author":"Y Kang","year":"2025","unstructured":"Kang Y, Meng L, Bai S et al (2025) Extracellular vesicles: the Trojan Horse within breast cancer host microenvironments. Mol Cancer 24:183. https:\/\/doi.org\/10.1186\/s12943-025-02358-y","journal-title":"Mol Cancer"},{"key":"10432_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12943-025-02235-8","volume":"24","author":"T Cheytan","year":"2025","unstructured":"Cheytan T, Schneider M, W\u00fcrth R et al (2025) Small extracellular vesicles and particles (sEVPs) derived from tumor-free pre-metastatic organs promote breast cancer metastasis and support organotropism. Mol Cancer 24:72. https:\/\/doi.org\/10.1186\/s12943-025-02235-8","journal-title":"Mol Cancer"},{"key":"10432_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10585-023-10256-0","volume":"41","author":"ETY Mok","year":"2024","unstructured":"Mok ETY, Chitty JL, Cox TR (2024) miRNAs in pancreatic cancer progression and metastasis. Clin Exp Metastasis 41:163\u2013186. https:\/\/doi.org\/10.1007\/s10585-023-10256-0","journal-title":"Clin Exp Metastasis"},{"key":"10432_CR8","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/s41467-018-06434-4","volume":"9","author":"A Yokoi","year":"2018","unstructured":"Yokoi A, Matsuzaki J, Yamamoto Y et al (2018) Integrated extracellular microRNA profiling for ovarian cancer screening. Nat Commun 9:4319. https:\/\/doi.org\/10.1038\/s41467-018-06434-4","journal-title":"Nat Commun"},{"issue":"14","key":"10432_CR9","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X (2020) miRNA-based biomarkers, therapies, and resistance in cancer. Int J Biol Sci 16(14):2628\u20132647. https:\/\/doi.org\/10.7150\/ijbs.47203","journal-title":"Int J Biol Sci"},{"key":"10432_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12938-021-00857-9","volume":"20","author":"LJ Galv\u00e3o-Lima","year":"2021","unstructured":"Galv\u00e3o-Lima LJ, Morais AHF, Valentim RAM et al (2021) miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. BioMed Eng OnLine 20:21. https:\/\/doi.org\/10.1186\/s12938-021-00857-9","journal-title":"BioMed Eng OnLine"},{"key":"10432_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12967-021-03215-4","volume":"20","author":"C Li","year":"2022","unstructured":"Li C, Zhou T, Chen J et al (2022) The role of exosomal miRNAs in cancer. J Transl Med 20:6. https:\/\/doi.org\/10.1186\/s12967-021-03215-4","journal-title":"J Transl Med"},{"key":"10432_CR12","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.3390\/ijms21165840","volume":"21","author":"W Olejarz","year":"2020","unstructured":"Olejarz W, Kubiak-Tomaszewska G, Chrzanowska A, Lorenc T (2020) Exosomes in angiogenesis and anti-angiogenic therapy in cancers. Int J Mol Sci 21:5840. https:\/\/doi.org\/10.3390\/ijms21165840","journal-title":"Int J Mol Sci"},{"key":"10432_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-020-01570-6","volume":"39","author":"S Tan","year":"2020","unstructured":"Tan S, Xia L, Yi P et al (2020) Exosomal miRNAs in tumor microenvironment. J Exp Clin Cancer Res 39:67. https:\/\/doi.org\/10.1186\/s13046-020-01570-6","journal-title":"J Exp Clin Cancer Res"},{"key":"10432_CR14","doi-asserted-by":"publisher","first-page":"836548","DOI":"10.3389\/fonc.2022.836548","volume":"12","author":"K Liu","year":"2022","unstructured":"Liu K, Gao X, Kang B, Liu Y, Wang D, Wang Y (2022) The role of tumor stem cell exosomes in cancer invasion and metastasis. Front Oncol 12:836548. https:\/\/doi.org\/10.3389\/fonc.2022.836548","journal-title":"Front Oncol"},{"issue":"1","key":"10432_CR15","doi-asserted-by":"publisher","first-page":"10539","DOI":"10.1038\/s41467-024-54706-z","volume":"15","author":"MX Li","year":"2024","unstructured":"Li MX, Hu S, Lei HH, Yuan M, Li X, Hou WK, Huang XJ, Xiao BW, Yu TX, Zhang XH, Wu XT, Jing WQ, Lee HJ, Li JJ, Fu D, Zhang LM, Yan W (2024) Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice. Nat Commun 15(1):10539. https:\/\/doi.org\/10.1038\/s41467-024-54706-z","journal-title":"Nat Commun"},{"issue":"7","key":"10432_CR16","doi-asserted-by":"publisher","first-page":"10415","DOI":"10.18632\/aging.202802","volume":"13","author":"WX Chen","year":"2021","unstructured":"Chen WX, Wang DD, Zhu B, Zhu YZ, Zheng L, Feng ZQ, Qin XH (2021) Exosomal miR-222 from adriamycin-resistant MCF-7 breast cancer cells promote macrophages M2 polarization via PTEN\/Akt to induce tumor progression. Aging 13(7):10415\u201310430 Epub 2021 Mar 22. https:\/\/doi.org\/10.18632\/aging.202802","journal-title":"Aging"},{"issue":"8","key":"10432_CR17","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.53412","volume":"11","author":"B Chen","year":"2021","unstructured":"Chen B, Sang Y, Song X, Zhang D, Wang L, Zhao W, Liang Y, Zhang N, Yang Q (2021) Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics 11(8):3932\u20133947. https:\/\/doi.org\/10.7150\/thno.53412","journal-title":"Theranostics"},{"issue":"3","key":"10432_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.7150\/thno.45351","volume":"11","author":"X Yuan","year":"2021","unstructured":"Yuan X, Qian N, Ling S, Li Y, Sun W, Li J, Du R, Zhong G, Liu C, Yu G, Cao D, Liu Z, Wang Y, Qi Z, Yao Y, Wang F, Liu J, Hao S, Jin X, Zhao Y, Xue J, Zhao D, Gao X, Liang S, Li Y, Song J, Yu S, Li Y (2021) Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells. Theranostics 11(3):1429\u20131445. https:\/\/doi.org\/10.7150\/thno.45351","journal-title":"Theranostics"},{"issue":"1","key":"10432_CR19","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1038\/s41467-021-25473-y","volume":"12","author":"K Wu","year":"2021","unstructured":"Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, Wu SY, Zhao D, Tyagi A, Deshpande RP, Pei X, Ruiz MG, Takahashi H, Tsuzuki S, Kimura T, Mo YY, Shiozawa Y, Singh R, Watabe K (2021) Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun 12(1):5196. https:\/\/doi.org\/10.1038\/s41467-021-25473-y","journal-title":"Nat Commun"},{"issue":"3","key":"10432_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3892\/ijmm.2023.5287","volume":"52","author":"O Kim","year":"2023","unstructured":"Kim O, Tran PT, Gal M, Lee SJ, Na SH, Hwangbo C, Lee JH (2023) RASstimulated release of exosomal miR 494 3p promotes the osteolytic bone metastasis of breast cancer cells. Int J Mol Med 52(3):84 Epub 2023 Jul 28. https:\/\/doi.org\/10.3892\/ijmm.2023.5287","journal-title":"Int J Mol Med"},{"issue":"51","key":"10432_CR21","first-page":"85995","volume":"7","author":"J Luo","year":"2016","unstructured":"Luo J et al (2016) Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple-negative breast cancer cells. Oncotarget 7(51):85995\u201386011 [\u0424\u0418\u041d\u0410\u041b\u042c\u041d\u041e \u0421\u0412\u0415\u0420\u0418\u0422\u042c \u0432\u044b\u0445\u043e\u0434\u043d\u044b\u0435 \u0434\u0430\u043d\u043d\u044b\u0435]","journal-title":"Oncotarget"},{"key":"10432_CR22","doi-asserted-by":"publisher","unstructured":"Croset M, Pantano F, Kan CW, Bonnelye E, Descotes F, Alix-Panabi\u00e8res C, Lecellier CH, Bachelier R, Allioli N, Hong SS, Bartkowiak K (2018) miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis\u2013associated genes. Cancer Res 78(18):5259\u20135273. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3058","DOI":"10.1158\/0008-5472.CAN-17-3058"},{"key":"10432_CR23","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1002\/jcp.29507","volume":"235","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang Q, Wang D et al (2020) Microenvironment-induced TIMP2 loss by cancer-secreted exosomal miR-4443 promotes liver metastasis of breast cancer. J Cell Physiol 235:5722\u20135735. https:\/\/doi.org\/10.1002\/jcp.29507","journal-title":"J Cell Physiol"},{"key":"10432_CR24","doi-asserted-by":"publisher","first-page":"7461727","DOI":"10.1155\/2020\/7461727","volume":"1","author":"Y Lu","year":"2020","unstructured":"Lu Y et al (2020) Exosomes derived from brain metastatic breast cancer cells destroy the blood-brain barrier by carrying lncRNA GS1\u2010600G8. 5. BioMed Res Int 1:7461727","journal-title":"BioMed Res Int"},{"issue":"11","key":"10432_CR25","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.3390\/ijms21113851","volume":"21","author":"G Morad","year":"2020","unstructured":"Morad G et al (2020) Cdc42-dependent transfer of mir301 from breast cancer-derived extracellular vesicles regulates the matrix modulating ability of astrocytes at the blood\u2013brain barrier. Int J Mol Sci 21(11):3851","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10432_CR26","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1074\/jbc.M112.446831","volume":"288","author":"N Kosaka","year":"2013","unstructured":"Kosaka N et al (2013) Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 288(15):10849\u201310859","journal-title":"J Biol Chem"},{"key":"10432_CR27","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2001","author":"V Gerke","year":"2002","unstructured":"Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00030.2001","journal-title":"Physiol Rev"},{"issue":"4","key":"10432_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/gb-2004-5-4-219","volume":"5","author":"SE Moss","year":"2004","unstructured":"Moss SE, Morgan RO (2004) The annexins. Genome Biol 5(4):219","journal-title":"Genome Biol"},{"key":"10432_CR29","doi-asserted-by":"publisher","first-page":"1009908","DOI":"10.3389\/fcell.2022.1009908","volume":"10","author":"L Prieto-Fern\u00e1ndez","year":"2022","unstructured":"Prieto-Fern\u00e1ndez L, Men\u00e9ndez ST, Otero-Rosales M, Montoro-Jim\u00e9nez I, Hermida-Prado F, Garc\u00eda-Pedrero JM, \u00c1lvarez-Teijeiro S (2022) Pathobiological functions and clinical implications of annexin dysregulation in human cancers. Front Cell Dev Biol 10:1009908. https:\/\/doi.org\/10.3389\/fcell.2022.1009908","journal-title":"Front Cell Dev Biol"},{"key":"10432_CR30","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41467-024-45954-0","volume":"15","author":"V Gerke","year":"2024","unstructured":"Gerke V, Gavins FNE, Geisow M et al (2024) Annexins\u2014a family of proteins with distinctive tastes for cell signaling and membrane dynamics. Nat Commun 15:1574. https:\/\/doi.org\/10.1038\/s41467-024-45954-0","journal-title":"Nat Commun"},{"key":"10432_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00249-023-01687-4","volume":"52","author":"CR Ferreira","year":"2023","unstructured":"Ferreira CR, Cruz MAE, Bolean M et al (2023) Annexin A5 stabilizes matrix vesicle-biomimetic lipid membranes: unravelling a new role of annexins in calcification. Eur Biophys J 52:721\u2013733. https:\/\/doi.org\/10.1007\/s00249-023-01687-4","journal-title":"Eur Biophys J"},{"key":"10432_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110591","volume":"130","author":"Y Xi","year":"2020","unstructured":"Xi Y, Ju Y, Wang Y (2020) Roles of annexin A protein family in autophagy regulation and therapy. Biomed Pharmacother 130:110591. https:\/\/doi.org\/10.1016\/j.biopha.2020.110591","journal-title":"Biomed Pharmacother"},{"key":"10432_CR33","doi-asserted-by":"publisher","first-page":"e592","DOI":"10.1002\/cpz1.592","volume":"2","author":"AT Hagymasi","year":"2022","unstructured":"Hagymasi AT, Dempsey JP, Srivastava PK (2022) Heat-shock proteins. Curr Protocols 2:e592. https:\/\/doi.org\/10.1002\/cpz1.592","journal-title":"Curr Protocols"},{"key":"10432_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00204-012-0918-z","volume":"87","author":"DR Ciocca","year":"2013","unstructured":"Ciocca DR, Arrigo AP, Calderwood SK (2013) Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch Toxicol 87:19\u201348. https:\/\/doi.org\/10.1007\/s00204-012-0918-z","journal-title":"Arch Toxicol"},{"key":"10432_CR35","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s00018-021-03764-3","volume":"78","author":"L Secl\u00ec","year":"2021","unstructured":"Secl\u00ec L, Fusella F, Avalle L et al (2021) The dark-side of the outside: how extracellular heat shock proteins promote cancer. Cell Mol Life Sci 78:4069\u20134083. https:\/\/doi.org\/10.1007\/s00018-021-03764-3","journal-title":"Cell Mol Life Sci"},{"key":"10432_CR36","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1002\/ctd2.341","volume":"4","author":"A Das","year":"2024","unstructured":"Das A, Saha P, Kalele K, Sonar S (2024) Clinical signature of exosomal tetraspanin proteins in cancer. Clin Transl Disc 4:e341. https:\/\/doi.org\/10.1002\/ctd2.341","journal-title":"Clin Transl Disc"},{"key":"10432_CR37","doi-asserted-by":"publisher","unstructured":"Fujii N, Yashiro M, Hatano T, Fujikawa H, Motomura H (2023) CD9-positive exosomes derived from cancer-associated fibroblasts might inhibit the proliferation of malignant melanoma cells. Anticancer Res 43(1):2533. https:\/\/doi.org\/10.21873\/anticanres.16130","DOI":"10.21873\/anticanres.16130"},{"issue":"6","key":"10432_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/MPA.0000000000000847","volume":"46","author":"M Khushman","year":"2017","unstructured":"Khushman M, Bhardwaj A, Patel GK, Laurini PJA, Roveda K, Tan MC, Patton MC, Singh S, Taylor W, Singh AP (2017) Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens. Pancreas 46(6):782\u2013788. https:\/\/doi.org\/10.1097\/MPA.0000000000000847","journal-title":"Pancreas"},{"issue":"4","key":"10432_CR39","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.18632\/oncotarget.2958","volume":"6","author":"S Yue","year":"2015","unstructured":"Yue S, Mu W, Erb U, Z\u00f6ller M (2015) The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding. Oncotarget 6(4):2366\u20132384. https:\/\/doi.org\/10.18632\/oncotarget.2958","journal-title":"Oncotarget"},{"key":"10432_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13062-025-00623-0","volume":"20","author":"S Li","year":"2025","unstructured":"Li S, Fu X, Ning D et al (2025) Colon cancer exosome-associated HSP90B1 initiates pre-metastatic niche formation in the liver by polarizing M1 macrophage into M2 phenotype. Biol Direct 20:52. https:\/\/doi.org\/10.1186\/s13062-025-00623-0","journal-title":"Biol Direct"},{"key":"10432_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2025.107122","volume":"278","author":"X-W Xu","year":"2026","unstructured":"Xu X-W, Zhang Y, Zhao C-W, Wu H, Zhang M-T, Ma Y-T, Zheng YYL, Gu F, Chen Y-Q (2026) Lenvatinib-resistant liver cancer-derived HSP90\u03b1-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion. Immunol Lett 278:107122. https:\/\/doi.org\/10.1016\/j.imlet.2025.107122","journal-title":"Immunol Lett"},{"key":"10432_CR42","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/cells9030755","volume":"9","author":"T Eguchi","year":"2020","unstructured":"Eguchi T, Sogawa C, Ono K, Matsumoto M, Tran MT, Okusha Y, Lang BJ, Okamoto K, Calderwood SK (2020) Cell stress induced stressome release including damaged membrane vesicles and extracellular HSP90 by prostate cancer cells. Cells 9:755. https:\/\/doi.org\/10.3390\/cells9030755","journal-title":"Cells"},{"key":"10432_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12964-020-00611-z","volume":"18","author":"Y Gao","year":"2020","unstructured":"Gao Y, Xu H, Li N et al (2020) Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression. Cell Commun Signal 18:106. https:\/\/doi.org\/10.1186\/s12964-020-00611-z","journal-title":"Cell Commun Signal"},{"issue":"2","key":"10432_CR44","doi-asserted-by":"publisher","first-page":"113565","DOI":"10.1016\/j.yexcr.2023.113565","volume":"426","author":"S Yu","year":"2023","unstructured":"Yu S, Yu WXY, Jiang Y, Xiao Z, Huang D, Zhong T, Li J, Xiang X, He Y, Li Z (2023) Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression. Exp Cell Res 426(2):113565. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113565","journal-title":"Exp Cell Res"},{"key":"10432_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123446","volume":"10","author":"AE Kabakov","year":"2021","unstructured":"Kabakov AE, Gabai VL (2021) HSP70s in breast cancer: promoters of tumorigenesis and potential targets\/tools for therapy. Cells 10:3446. https:\/\/doi.org\/10.3390\/cells10123446","journal-title":"Cells"},{"key":"10432_CR46","doi-asserted-by":"publisher","unstructured":"Basset CA et al (2020) Chaperonin Hsp60 and Cancer Therapies. In: Asea AAA, Kaur P (eds) Heat shock proteins in human diseases. Heat shock proteins, vol 21. Springer, Cham. https:\/\/doi.org\/10.1007\/7515_2020_1","DOI":"10.1007\/7515_2020_1"},{"key":"10432_CR47","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/cells9122719","volume":"9","author":"N Novizio","year":"2020","unstructured":"Novizio N, Belvedere R, Pessolano E, Tosco A, Porta A, Perretti M, Campiglia P, Filippelli A, Petrella A (2020) Annexin A1 released in extracellular vesicles by pancreatic cancer cells activates components of the tumor microenvironment, through interaction with the formyl-peptide receptors. Cells 9:2719. https:\/\/doi.org\/10.3390\/cells9122719","journal-title":"Cells"},{"key":"10432_CR48","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/cells10061472","volume":"10","author":"L Vecchi","year":"2021","unstructured":"Vecchi L, Ara\u00fajo TG, Azevedo FVPdV, Mota STS, \u00c1vila VdMR, Ribeiro MA, Goulart LR (2021) Phospholipase A2 drives tumorigenesis and cancer aggressiveness through its interaction with annexin A1. Cells 10:1472. https:\/\/doi.org\/10.3390\/cells10061472","journal-title":"Cells"},{"key":"10432_CR49","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1186\/s12885-022-10075-8","volume":"22","author":"T Hein","year":"2022","unstructured":"Hein T, Krammer PH, Weyd H (2022) Molecular analysis of annexin expression in cancer. BMC Cancer 22:994. https:\/\/doi.org\/10.1186\/s12885-022-10075-8","journal-title":"BMC Cancer"},{"key":"10432_CR50","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","volume":"21","author":"I Keklikoglou","year":"2019","unstructured":"Keklikoglou I, Cianciaruso C, G\u00fc\u00e7 E et al (2019) Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol 21:190\u2013202. https:\/\/doi.org\/10.1038\/s41556-018-0256-3","journal-title":"Nat Cell Biol"},{"issue":"21","key":"10432_CR51","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.3390\/ijms262110331","volume":"26","author":"J Gorospe","year":"2025","unstructured":"Gorospe J, Shapiro M, Simhadri VR (2025) Analyses of exosomal HER2 in breast cancer and the effect of respective exosome-immune complexes on trastuzumab-based immunotherapy. Int J Mol Sci 26(21):10331. https:\/\/doi.org\/10.3390\/ijms262110331","journal-title":"Int J Mol Sci"},{"key":"10432_CR52","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1021\/acs.analchem.3c00772","volume":"95","author":"A Kowalczyk","year":"2023","unstructured":"Kowalczyk A, Gajda-Walczak A, Ruzycka-Ayoush M, Targonska A, Mosieniak G, Glogowski M, Szumera-Cieckiewicz A, Prochorec-Sobieszek M, Bamburowicz-Klimkowska M, Nowicka AM, Grudzinski IP (2023) Parallel SPR and QCM-D quantitative analysis of CD9, CD63, and CD81 tetraspanins: a simple and sensitive way to determine the concentration of extracellular vesicles isolated from human lung cancer cells. Anal Chem 95:9520\u20139530. https:\/\/doi.org\/10.1021\/acs.analchem.3c00772","journal-title":"Anal Chem"},{"key":"10432_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.201037","author":"A Paramanantham","year":"2025","unstructured":"Paramanantham A, Das S, Asfiya R (2025) Perturbed CD81 in lung-cancer-derived extracellular vesicles modifies its function in cancer pathophysiology. Mol Ther Oncol. https:\/\/doi.org\/10.1016\/j.omton.2025.201037","journal-title":"Mol Ther Oncol"},{"key":"10432_CR54","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC (2024) Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med 56:877\u2013889. https:\/\/doi.org\/10.1038\/s12276-024-01209-y","journal-title":"Exp Mol Med"},{"issue":"3","key":"10432_CR55","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.200302131","volume":"162","author":"KG Bache","year":"2003","unstructured":"Bache KG et al (2003) Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 162(3):435\u2013442","journal-title":"J Cell Biol"},{"key":"10432_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41580-019-0177-4","volume":"21","author":"M Vietri","year":"2020","unstructured":"Vietri M, Radulovic M, Stenmark H (2020) The many functions of ESCRTs. Nat Rev Mol Cell Biol 21:25\u201342. https:\/\/doi.org\/10.1038\/s41580-019-0177-4","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10432_CR57","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature07961","volume":"458","author":"C Raiborg","year":"2009","unstructured":"Raiborg C, Stenmark H (2009) The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458:445\u2013452","journal-title":"Nature"},{"key":"10432_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00409-1","author":"D Wei","year":"2020","unstructured":"Wei D et al (2020) Cell Res. https:\/\/doi.org\/10.1038\/s41422-020-00409-1","journal-title":"Cell Res"},{"key":"10432_CR59","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic K et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244\u20131247","journal-title":"Science"},{"key":"10432_CR60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"QF Han","year":"2022","unstructured":"Han QF, Li WJ, Hu KS et al (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21:207. https:\/\/doi.org\/10.1186\/s12943-022-01671-0","journal-title":"Mol Cancer"},{"key":"10432_CR61","doi-asserted-by":"publisher","first-page":"1100892","DOI":"10.3389\/fbioe.2022.1100892","volume":"10","author":"J Gao","year":"2023","unstructured":"Gao J, Li A, Hu J, Feng L, Liu L, Shen Z (2023) Recent developments in isolating methods for exosomes. Front Bioeng Biotechnol 10:1100892. https:\/\/doi.org\/10.3389\/fbioe.2022.1100892","journal-title":"Front Bioeng Biotechnol"},{"key":"10432_CR62","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00216-022-04174-5","volume":"415","author":"TS Martins","year":"2023","unstructured":"Martins TS, Vaz M, Henriques AG (2023) A review on comparative studies addressing exosome isolation methods from body fluids. Anal Bioanal Chem 415:1239\u20131263. https:\/\/doi.org\/10.1007\/s00216-022-04174-5","journal-title":"Anal Bioanal Chem"},{"issue":"12","key":"10432_CR63","doi-asserted-by":"publisher","first-page":"szaf064","DOI":"10.1093\/stcltm\/szaf064","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Xu Y, Zheng Y, Yan Y, Cai J, Hua C, Li J, Zhang C, Lauwers M, Rao Y, Zhong Z, Ker DFE, Tuan RS, Yang X, Wang DM, Zhang Z (2025) Harnessing 3D cultured MSC exosomes through tangential flow filtration for enhanced diabetic wound healing. Stem Cells Transl Med 14(12):szaf064. https:\/\/doi.org\/10.1093\/stcltm\/szaf064","journal-title":"Stem Cells Transl Med"},{"key":"10432_CR64","doi-asserted-by":"publisher","unstructured":"Thomas S, Kaur J, Kamboj R, Thangariyal S, Yadav R, Kumar K, Dhania NK (2024) Investigate the efficacy of size exclusion chromatography for the isolation of extracellular vesicles from C. elegans. J Chromatogr B 1233:123982. https:\/\/doi.org\/10.1016\/j.jchromb.2023.123982","DOI":"10.1016\/j.jchromb.2023.123982"},{"key":"10432_CR65","doi-asserted-by":"publisher","unstructured":"Sharif S, Mozaffari-Jovin S, Alizadeh F, Mojarrad M, Baharvand H, Nouri M, Abbaszadegan MR (2023) Isolation of plasma small extracellular vesicles by an optimized size-exclusion chromatography-based method for clinical applications. J Drug Deliv Sci Technol 87:104796. https:\/\/doi.org\/10.1016\/j.jddst.2023.104796","DOI":"10.1016\/j.jddst.2023.104796"},{"issue":"25","key":"10432_CR66","doi-asserted-by":"publisher","first-page":"8958","DOI":"10.1021\/acs.analchem.2c00806","volume":"94","author":"YB Kim","year":"2022","unstructured":"Kim YB, Lee GB, Moon MH (2022) Size separation of exosomes and microvesicles using flow field-flow fractionation\/multiangle light scattering and lipidomic comparison. Anal Chem 94(25):8958\u20138965. https:\/\/doi.org\/10.1021\/acs.analchem.2c00806","journal-title":"Anal Chem"},{"key":"10432_CR67","doi-asserted-by":"publisher","unstructured":"Wu Y, Wang Y, Lu Y, Luo X, Huang Y, Xie T, Pilarsky C, Dang Y, Zhang J (2022) Microfluidic technology for the isolation and analysis of exosomes. Micromachines 13:1571. https:\/\/doi.org\/10.3390\/mi13101571","DOI":"10.3390\/mi13101571"},{"key":"10432_CR68","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong R, Xu B (2022) Breast cancer: an up-to-date review and future perspectives. Cancer Commun 42:913\u2013936. https:\/\/doi.org\/10.1002\/cac2.12358","journal-title":"Cancer Commun"},{"issue":"3","key":"10432_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249","journal-title":"Cancer J Clin"},{"key":"10432_CR70","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3390\/cancers14102569","volume":"14","author":"B Smolarz","year":"2022","unstructured":"Smolarz B, Nowak AZ, Romanowicz H (2022) Breast cancer\u2014epidemiology, classification, pathogenesis and treatment (review of literature). Cancers 14:2569. https:\/\/doi.org\/10.3390\/cancers14102569","journal-title":"Cancers"},{"key":"10432_CR71","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/cam4.1370","volume":"7","author":"W Xiao","year":"2018","unstructured":"Xiao W, Zheng S, Liu P, Zou Y, Xie X, Yu P, Tang H, Xie X (2018) Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study. Cancer Med 7:922\u2013930. https:\/\/doi.org\/10.1002\/cam4.1370","journal-title":"Cancer Med"},{"key":"10432_CR72","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10585-021-10080-4","volume":"38","author":"NS Rashid","year":"2021","unstructured":"Rashid NS, Grible JM, Clevenger CV et al (2021) Breast cancer liver metastasis: current and future treatment approaches. Clin Exp Metastasis 38:263\u2013277. https:\/\/doi.org\/10.1007\/s10585-021-10080-4","journal-title":"Clin Exp Metastasis"},{"key":"10432_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-20301-6_7","volume-title":"Breast Cancer Metastasis and Drug Resistance. Advances in Experimental Medicine and Biology","author":"RK Tahara","year":"2019","unstructured":"Tahara RK, Brewer TM, Theriault RL, Ueno NT (2019) Bone metastasis of breast cancer. In: Ahmad A (ed) Breast cancer metastasis and drug resistance. Advances in experimental medicine and biology, vol 1152. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-20301-6_7"},{"key":"10432_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2026.03.002","author":"GS Carvalho","year":"2026","unstructured":"Carvalho GS, Rodrigues FR, Fernandes PV, Small I\u00c1, da Silva JL, Araujo LHL (2026) Real-world evidence of immunohistochemical discordance in breast cancer brain metastases. Clin Breast Cancer. https:\/\/doi.org\/10.1016\/j.clbc.2026.03.002","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10432_CR75","doi-asserted-by":"publisher","first-page":"e103428","DOI":"10.7759\/cureus.103428","volume":"18","author":"S Mainer","year":"2026","unstructured":"Mainer S, Lachmayr H, Lemon B, Killorin W (2026) Breast cancer metastasis with a ureteral obstruction and bladder mass. Cureus 18(2):e103428. https:\/\/doi.org\/10.7759\/cureus.103428","journal-title":"Cureus"},{"key":"10432_CR76","doi-asserted-by":"publisher","first-page":"1598840","DOI":"10.3389\/fonc.2025.1598840","volume":"15","author":"R Deng","year":"2025","unstructured":"Deng R, Meng Z, Li Q, Wang Y, Lan Y, Liu Y, Liu Y (2025) Case report: synchronous cervical, gastric and rectal metastases in occult breast cancer. Front Oncol 15:1598840. https:\/\/doi.org\/10.3389\/fonc.2025.1598840","journal-title":"Front Oncol"},{"key":"10432_CR77","doi-asserted-by":"publisher","unstructured":"77.\tDeng F, Knipe H, Campos A, et al. WHO classification of breast tumours (5th edn). Reference article, Radiopaedia.org. https:\/\/doi.org\/10.53347\/rID-70716","DOI":"10.53347\/rID-70716"},{"key":"10432_CR78","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.3390\/cancers14235727","volume":"14","author":"L Pang","year":"2022","unstructured":"Pang L, Gan C, Xu J, Jia Y, Chai J, Huang R, Li A, Ge H, Yu S, Cheng H (2022) Bone metastasis of breast cancer: molecular mechanisms and therapeutic strategies. Cancers 14:5727. https:\/\/doi.org\/10.3390\/cancers14235727","journal-title":"Cancers"},{"key":"10432_CR79","doi-asserted-by":"publisher","first-page":"978985","DOI":"10.3389\/fonc.2023.978985","volume":"13","author":"J-H Fan","year":"2023","unstructured":"Fan J-H, Zhang S, Yang H, Yi Z-B, Ouyang Q-C, Yan M, Wang X-J, Hu X-C, Jiang Z-F, Huang T, Tong Z-S, Wang S-S, Yin Y-M, Li H, Yang R-X, Yang H-W, Teng Y-E, Sun T, Cai L, Li H-Y, Ouyang X-N, He J-J, Liu X-L, Yang S-E, Wang J-Y, Xu B-H, Qiao Y-L (2023) Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study. Front Oncol 13:978985. https:\/\/doi.org\/10.3389\/fonc.2023.978985","journal-title":"Front Oncol"},{"issue":"3","key":"10432_CR80","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568010054022015","volume":"4","author":"Y Tanaka","year":"2005","unstructured":"Tanaka Y, Nakayamada S, Okada Y (2005) Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets-Inflammation Allergy 4(3):325\u2013328","journal-title":"Curr Drug Targets-Inflammation Allergy"},{"issue":"11","key":"10432_CR81","doi-asserted-by":"publisher","first-page":"a041326","DOI":"10.1101\/cshperspect.a041326","volume":"13","author":"E Nolan","year":"2023","unstructured":"Nolan E, Kang Y, Malanchi I (2023) Mechanisms of Organ-Specific Metastasis of Breast Cancer. Cold Spring Harb Perspect Med 13(11):a041326. https:\/\/doi.org\/10.1101\/cshperspect.a041326","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10432_CR82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41420-024-01897-5","volume":"10","author":"Z Liu","year":"2024","unstructured":"Liu Z, Xin B, Zhang N et al (2024) LSD1 modulates the bone metastasis of breast cancer cells through hnRNPA2B1-mediated sorting of exosomal miRNAs. Cell Death Discov 10:115. https:\/\/doi.org\/10.1038\/s41420-024-01897-5","journal-title":"Cell Death Discov"},{"issue":"11","key":"10432_CR83","doi-asserted-by":"publisher","first-page":"14971","DOI":"10.1021\/acsnano.0c04778","volume":"14","author":"J Kim","year":"2020","unstructured":"Kim J, Lee C, Kim I, Ro J, Kim J, Min Y, Park J, Sunkara V, Park YS, Michael I, Kim YA, Lee HJ, Cho YK (2020) Three-dimensional human liver-chip emulating premetastatic niche formation by breast cancer-derived extracellular vesicles. ACS Nano 14(11):14971\u201314988. https:\/\/doi.org\/10.1021\/acsnano.0c04778","journal-title":"ACS Nano"},{"issue":"7","key":"10432_CR84","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/1541-7786.MCR-22-0673","volume":"21","author":"W Woohang Heo","year":"2023","unstructured":"Woohang Heo W, Lee JH, Cheun E-S, Lee S, Li Hsuk, Kim H-Y, Son JH, Kim YD, Woo DH, Chung J, Yun JG, Jung H-B, Lee W, Han H-K, Kim J-I, Kim H-G (2023) Triple-negative breast cancer-derived extracellular vesicles promote a hepatic premetastatic niche via a cascade of microenvironment remodeling. Mol Cancer Res 1 July 21(7):726\u2013740. https:\/\/doi.org\/10.1158\/1541-7786.MCR-22-0673","journal-title":"Mol Cancer Res 1 July"},{"key":"10432_CR85","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13046-025-03418-3","volume":"44","author":"A Nadeau","year":"2025","unstructured":"Nadeau A, Tsering T, Abdouh M et al (2025) Characterization of extracellular vesicle-associated DNA and proteins derived from organotropic metastatic breast cancer cells. J Exp Clin Cancer Res 44:157. https:\/\/doi.org\/10.1186\/s13046-025-03418-3","journal-title":"J Exp Clin Cancer Res"},{"key":"10432_CR86","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13402-018-0376-6","volume":"41","author":"M Yousefi","year":"2018","unstructured":"Yousefi M, Nosrati R, Salmaninejad A et al (2018) Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis. Cell Oncol 41:123\u2013140. https:\/\/doi.org\/10.1007\/s13402-018-0376-6","journal-title":"Cell Oncol"},{"key":"10432_CR87","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Li CW, Chan LC et al (2018) Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res 28:862\u2013864. https:\/\/doi.org\/10.1038\/s41422-018-0060-4","journal-title":"Cell Res"},{"key":"10432_CR88","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41467-022-28438-x","volume":"13","author":"M Qi","year":"2022","unstructured":"Qi M, Xia Y, Wu Y et al (2022) Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression. Nat Commun 13:897. https:\/\/doi.org\/10.1038\/s41467-022-28438-x","journal-title":"Nat Commun"},{"issue":"7","key":"10432_CR89","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.7150\/thno.82700","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Li M, Su K, Zong S, Zhang H, Xiong L (2023) Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis. Theranostics 13(7):2301\u20132318. https:\/\/doi.org\/10.7150\/thno.82700","journal-title":"Theranostics"},{"issue":"12","key":"10432_CR90","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1172\/JCI75695","volume":"124","author":"MT Le","year":"2014","unstructured":"Le MT et al (2014) miR-200\u2013containing extracellular vesicles promote breast cancer cell metastasis. J Clin Invest 124(12):5109\u20135128","journal-title":"J Clin Invest"},{"key":"10432_CR91","doi-asserted-by":"publisher","first-page":"657158","DOI":"10.3389\/fcell.2021.657158","volume":"9","author":"P Gu","year":"2021","unstructured":"Gu P, Sun M, Li L et al (2021) Breast tumor-derived exosomal MicroRNA-200b-3p promotes specific organ metastasis through regulating CCL2 expression in lung epithelial cells. Front Cell Dev Biol 9:657158. https:\/\/doi.org\/10.3389\/fcell.2021.657158","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10432_CR92","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/onc.2016.229","volume":"36","author":"Z Deng","year":"2017","unstructured":"Deng Z et al (2017) Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene 36(5):639\u2013651","journal-title":"Oncogene"},{"issue":"2","key":"10432_CR93","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ncb3094","volume":"17","author":"MY Fong","year":"2015","unstructured":"Fong MY et al (2015) Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 17(2):183\u2013194","journal-title":"Nat Cell Biol"},{"key":"10432_CR94","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41388-024-03237-4","volume":"44","author":"T Tang","year":"2025","unstructured":"Tang T, Yang T, Xue H et al (2025) Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis. Oncogene 44:601\u2013617. https:\/\/doi.org\/10.1038\/s41388-024-03237-4","journal-title":"Oncogene"},{"issue":"11","key":"10432_CR95","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/neuonc\/noy044","volume":"20","author":"RMSM Pedrosa","year":"2018","unstructured":"Pedrosa RMSM, DAMustafa R, Soffietti JM Kros (2018) Breast cancer brain metastasis:molecular mechanisms and directions for treatment. Neuro-Oncology 20(11):1439\u20131449. https:\/\/doi.org\/10.1093\/neuonc\/noy044","journal-title":"Neuro-Oncology"},{"key":"10432_CR96","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10555-020-09881-y","volume":"39","author":"M Hosonaga","year":"2020","unstructured":"Hosonaga M, Saya H, Arima Y (2020) Molecular and cellular mechanisms underlying brain metastasis of breast cancer. Cancer Metastasis Rev 39:711\u2013720. https:\/\/doi.org\/10.1007\/s10555-020-09881-y","journal-title":"Cancer Metastasis Rev"},{"key":"10432_CR97","doi-asserted-by":"crossref","unstructured":"Fan J, Fu BM (2016) Quantification of malignant breast cancer cell MDA-MB-231 transmigration across brain and lung microvascular endothelium. Ann Biomed Eng 44(7):2189\u20132201","DOI":"10.1007\/s10439-015-1517-y"},{"issue":"1","key":"10432_CR98","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1038\/ncomms7716","volume":"6","author":"N Tominaga","year":"2015","unstructured":"Tominaga N et al (2015) Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood\u2013brain barrier. Nat Commun 6(1):6716","journal-title":"Nat Commun"},{"issue":"1","key":"10432_CR99","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13046-020-01712-w","volume":"39","author":"J Arnold","year":"2020","unstructured":"Arnold J et al (2020) Tubulin tyrosine ligase like 4 (TTLL4) overexpression in breast cancer cells is associated with brain metastasis and alters exosome biogenesis. J Experimental Clin Cancer Res 39(1):205","journal-title":"J Experimental Clin Cancer Res"},{"key":"10432_CR100","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","volume":"21","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues G, Hoshino A, Kenific CM et al (2019) Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat Cell Biol 21:1403\u20131412. https:\/\/doi.org\/10.1038\/s41556-019-0404-4","journal-title":"Nat Cell Biol"},{"key":"10432_CR101","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.omto.2020.03.001","volume":"17","author":"W Xiao","year":"2020","unstructured":"Xiao W, Zheng S, Xie X, Li X, Zhang L, Yang A, Wang J, Tang H, Xie X (2020) SOX2 promotes brain metastasis of breast cancer by upregulating the expression of FSCN1 and HBEGF. Mol Ther Oncolytics 17:118\u2013129. https:\/\/doi.org\/10.1016\/j.omto.2020.03.001","journal-title":"Mol Ther Oncolytics"},{"key":"10432_CR102","doi-asserted-by":"publisher","first-page":"796776","DOI":"10.3389\/fgene.2021.796776","volume":"12","author":"Y Huang","year":"2022","unstructured":"Huang Y et al (2022) Comprehensive assessment of serum hsa_circ_0070354 as a novel diagnostic and predictive biomarker in non-small cell lung cancer. Front Genet 12:796776","journal-title":"Front Genet"},{"key":"10432_CR103","doi-asserted-by":"publisher","first-page":"1603855","DOI":"10.3389\/fimmu.2025.1603855","volume":"16","author":"T Kansha","year":"2025","unstructured":"Kansha T, Ma X, Wang H, Yu X, Song Y, Guo Z, Song J, Xue L, Yang J (2025) Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy. Front Immunol 16:1603855. https:\/\/doi.org\/10.3389\/fimmu.2025.1603855","journal-title":"Front Immunol"},{"issue":"1","key":"10432_CR104","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12967-022-03231-y","volume":"20","author":"K Hosseini","year":"2022","unstructured":"Hosseini K, Ranjbar M, Pirpour Tazehkand A, Asgharian P, Montazersaheb S, Tarhriz V, Ghasemnejad T (2022) Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing. J Transl Med 20(1):30. https:\/\/doi.org\/10.1186\/s12967-022-03231-y","journal-title":"J Transl Med"},{"issue":"42","key":"10432_CR105","doi-asserted-by":"publisher","first-page":"e40082","DOI":"10.1097\/MD.0000000000040082","volume":"103","author":"M Zhu","year":"2024","unstructured":"Zhu M, Gao Y, Zhu K, Yuan Y, Bai H, Meng L (2024) Exosomal miRNA as biomarker in cancer diagnosis and prognosis: a review. Medicine 103(42):e40082. https:\/\/doi.org\/10.1097\/MD.0000000000040082","journal-title":"Medicine"},{"key":"10432_CR106","doi-asserted-by":"publisher","first-page":"1531940","DOI":"10.3389\/fimmu.2025.1531940","volume":"16","author":"XR Chen","year":"2025","unstructured":"Chen XR, Tan XY, Zhang ZL, Yuan JS, Song WQ (2025) ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancer. Front Immunol 16:1531940. https:\/\/doi.org\/10.3389\/fimmu.2025.1531940","journal-title":"Front Immunol"},{"key":"10432_CR107","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/iub.2182","volume":"72","author":"S Mohammadi","year":"2020","unstructured":"Mohammadi S, Yousefi F, Shabaninejad Z et al (2020) Exosomes and cancer: from oncogenic roles to therapeutic applications. IUBMB Life 72:724\u2013748. https:\/\/doi.org\/10.1002\/iub.2182","journal-title":"IUBMB Life"},{"key":"10432_CR108","doi-asserted-by":"publisher","first-page":"103565","DOI":"10.1016\/j.critrevonc.2021.103565","volume":"169","author":"NA Hanjani","year":"2022","unstructured":"Hanjani NA, Esmaelizad N, Zanganeh S, Gharavi AT, Heidarizadeh P, Radfar M, Omidi F, MacLoughlin R, Doroudian M (2022) Emerging role of exosomes as biomarkers in cancer treatment and diagnosis. Crit Rev Oncol\/Hematol 169:103565. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103565","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"10432_CR109","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41467-023-37403-1","volume":"14","author":"H Shin","year":"2023","unstructured":"Shin H et al (2023) Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers. Nat Commun 14(1):1644","journal-title":"Nat Commun"},{"key":"10432_CR110","doi-asserted-by":"publisher","first-page":"751079","DOI":"10.3389\/fcell.2021.751079","volume":"9","author":"H Chen","year":"2021","unstructured":"Chen H et al (2021) Exosomes, a new star for targeted delivery. Front Cell Dev Biol 9:751079","journal-title":"Front Cell Dev Biol"},{"key":"10432_CR111","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s12276-022-00744-w","volume":"54","author":"QW Liu","year":"2022","unstructured":"Liu QW, He Y, Xu WW (2022) Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer. Exp Mol Med 54:216\u2013225. https:\/\/doi.org\/10.1038\/s12276-022-00744-w","journal-title":"Exp Mol Med"},{"key":"10432_CR112","doi-asserted-by":"publisher","DOI":"10.4137\/CPath.S39925","author":"BB Shenoda","year":"2016","unstructured":"Shenoda BB, Ajit SK (2016) Modulation of immune responses by exosomes derived from antigen-presenting cells. Clin Med Insights: Pathol. https:\/\/doi.org\/10.4137\/CPath.S39925. 9s1","journal-title":"Clin Med Insights : Pathol"},{"issue":"4","key":"10432_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201700611","volume":"5","author":"Y Lin","year":"2018","unstructured":"Lin Y et al (2018) Exosome\u2013liposome hybrid nanoparticles deliver CRISPR\/Cas9 system in MSCs. Adv Sci 5(4):1700611","journal-title":"Adv Sci"},{"issue":"11","key":"10432_CR114","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.stemcr.2024.09.008","volume":"19","author":"M Fujita","year":"2024","unstructured":"Fujita M, Hatta T, Ikka T, Onishi T (2024) The urgent need for clear and concise regulations on exosome-based interventions. Stem Cell Rep 19(11):1517\u20131519. https:\/\/doi.org\/10.1016\/j.stemcr.2024.09.008","journal-title":"Stem Cell Rep"},{"issue":"6","key":"10432_CR115","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/10408363.2024.2309935","volume":"61","author":"\u00c1 Gonz\u00e1lez","year":"2024","unstructured":"Gonz\u00e1lez \u00c1, L\u00f3pez-Borrego S, Sand\u00faa A, Vales-Gomez M, Alegre E (2024) Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories. Crit Rev Clin Lab Sci 61(6):435\u2013457. https:\/\/doi.org\/10.1080\/10408363.2024.2309935","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"7","key":"10432_CR116","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1097\/JS9.0000000000002518","volume":"111","author":"C Wen","year":"2025","unstructured":"Wen C, Ma H, Xu L, Gu Z, Li H, Zhang Y, Liang Y, Xu X (2025) Recent advances in the clinical application of exosomes for disease diagnosis and therapeutic strategies. Int J Surg 111(7):4609\u20134628. https:\/\/doi.org\/10.1097\/JS9.0000000000002518","journal-title":"Int J Surg"},{"issue":"9Suppl","key":"10432_CR117","first-page":"PO5","volume":"84","author":"M Flowers","year":"2024","unstructured":"Flowers M et al (2024) Analysis of trends in funding of metastatic breast cancer research. Cancer Res 84(9Suppl):PO5\u2013P05","journal-title":"Cancer Res"},{"key":"10432_CR118","doi-asserted-by":"publisher","first-page":"1095388","DOI":"10.3389\/fimmu.2023.1095388","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Xia J, Xu S et al (2023) Experimental mouse models for translational human cancer research. Front Immunol 14:1095388. https:\/\/doi.org\/10.3389\/fimmu.2023.1095388","journal-title":"Front Immunol"},{"key":"10432_CR119","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO et al (2023) Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol 20:192\u2013206. https:\/\/doi.org\/10.1038\/s41571-022-00721-2","journal-title":"Nat Rev Clin Oncol"},{"key":"10432_CR120","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/bcr2803","volume":"13","author":"LX Yan","year":"2011","unstructured":"Yan LX, Wu QN, Zhang Y et al (2011) Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 13:R2. https:\/\/doi.org\/10.1186\/bcr2803","journal-title":"Breast Cancer Res"},{"key":"10432_CR121","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12032-025-02865-4","volume":"42","author":"S Das","year":"2025","unstructured":"Das S, Sahoo S, Pattanaik S et al (2025) Advancing breast cancer research: a comprehensive review of in vitro and in vivo experimental models. Med Oncol 42:316. https:\/\/doi.org\/10.1007\/s12032-025-02865-4","journal-title":"Med Oncol"},{"key":"10432_CR122","doi-asserted-by":"publisher","first-page":"23111","DOI":"10.3402\/jev.v3.23111","volume":"3","author":"A Cvjetkovic","year":"2014","unstructured":"Cvjetkovic A, Lotvall J, Lasser C (2014) The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles. J Extracell Vesicles 3:23111. https:\/\/doi.org\/10.3402\/jev.v3.23111","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"10432_CR123","doi-asserted-by":"publisher","first-page":"e13904","DOI":"10.1111\/cts.13904","volume":"17","author":"CK Wang","year":"2024","unstructured":"Wang CK, Tsai TH, Lee CH (2024) Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci 17(8):e13904. https:\/\/doi.org\/10.1111\/cts.13904","journal-title":"Clin Transl Sci"},{"key":"10432_CR124","doi-asserted-by":"publisher","first-page":"117845","DOI":"10.1016\/j.cca.2024.117845","volume":"557","author":"RM Ram Kumar","year":"2024","unstructured":"Ram Kumar RM, Rajan L, Joghee S (2024) Breast cancer derived exosomes: theragnostic perspectives and implications. Clin Chim Acta 557:117845. https:\/\/doi.org\/10.1016\/j.cca.2024.117845","journal-title":"Clin Chim Acta"},{"key":"10432_CR125","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12672-024-01007-y","volume":"15","author":"Extracellular vesicle-mediated","year":"2024","unstructured":"Extracellular vesicle-mediated (2024) drug delivery in breast cancer theranostics. Discov Oncol 15:150. https:\/\/doi.org\/10.1007\/s12672-024-01007-y","journal-title":"Discov Oncol"},{"issue":"5","key":"10432_CR126","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/pharmaceutics15051465","volume":"15","author":"H Jo","year":"2023","unstructured":"Jo H, Shim K, Jeoung D (2023) Exosomes: diagnostic and therapeutic implications in cancer. Pharmaceutics 15(5):1465. https:\/\/doi.org\/10.3390\/pharmaceutics15051465","journal-title":"Pharmaceutics"},{"issue":"2","key":"10432_CR127","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 13(2):e12404. https:\/\/doi.org\/10.1002\/jev2.12404","journal-title":"J Extracell Vesicles"},{"key":"10432_CR128","doi-asserted-by":"publisher","first-page":"102121","DOI":"10.1016\/j.tranon.2024.102121","volume":"50","author":"N Dilsiz","year":"2024","unstructured":"Dilsiz N (2024) A comprehensive review on recent advances in exosome isolation and characterization: toward clinical applications. Transl Oncol 50:102121. https:\/\/doi.org\/10.1016\/j.tranon.2024.102121","journal-title":"Transl Oncol"},{"key":"10432_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2024.101668","volume":"38","author":"FJ Ansari","year":"2024","unstructured":"Ansari FJ, Tafti HA, Amanzadeh A, Rabbani S, Shokrgozar MA, Heidari R, Behroozi J, Eyni H, Uversky VN, Ghanbari H (2024) Comparison of the efficiency of ultrafiltration, precipitation, and ultracentrifugation methods for exosome isolation. Biochem Biophys Rep 38:101668. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101668","journal-title":"Biochem Biophys Rep"},{"key":"10432_CR130","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11010-023-04756-6","volume":"479","author":"M Omrani","year":"2024","unstructured":"Omrani M, Beyrampour-Basmenj H, Jahanban-Esfahlan R et al (2024) Global trend in exosome isolation and application: an update concept in management of diseases. Mol Cell Biochem 479:679\u2013691. https:\/\/doi.org\/10.1007\/s11010-023-04756-6","journal-title":"Mol Cell Biochem"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10432-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-026-10432-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10432-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:17:47Z","timestamp":1791173867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-026-10432-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":130,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["10432"],"URL":"https:\/\/doi.org\/10.1007\/s10585-026-10432-y","relation":{},"ISSN":["1573-7276"],"issn-type":[{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"50"}}